Results of excimer laser correction of secondary ametropia in patients with pseudophakia

Excimer laser correction of secondary ametropia in patients after cataract phacoemulsification is becoming increasingly relevant due to the growing number of cataract surgeries. This study analyzed the results of 37 patients who underwent laser vision correction using LASIK and FEMTO LASIK methods. The patients were divided into two groups: the first group of 19 patients underwent LASIK, and the second group of 18 patients underwent FEMTO LASIK. A retrospective analysis of patient data over the past 4 years was conducted. One month after surgery, 92 % of patients in both groups showed significant improvement in uncorrected visual acuity. The average score was 0.88 ± 0.12 in the LASIK group and 1,0 ± 0.1 in the FEMTO LASIK group. After 12 months, 89 % of patients maintained stable results. The mean spherical equivalent after surgery was –0.25 ± 0.5 for LASIK and –0.2 ± 0.4 for FEMTO LASIK. Complications included dry eye syndrome in 13 % of patients and corneal epithelial defect in 6 % of patients in the LASIK group, which were successfully managed with conservative therapy. The results of the study confirm the high efficacy of excimer laser correction for eliminating secondary ametropia in patients with pseudophakia, with the FEMTO LASIK method showing better results compared to LASIK due to the higher precision and safety of the femtosecond laser. Keywords: cataract phacoemulsification, secondary ametropia treatment, excimer laser vision correction, pseudophakia